GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnax Lab Ltd (BOM:506128) » Definitions » EV-to-Revenue

Parnax Lab (BOM:506128) EV-to-Revenue : 1.01 (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Parnax Lab EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Parnax Lab's enterprise value is ₹1,847 Mil. Parnax Lab's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,832 Mil. Therefore, Parnax Lab's EV-to-Revenue for today is 1.01.

The historical rank and industry rank for Parnax Lab's EV-to-Revenue or its related term are showing as below:

BOM:506128' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.12   Med: 0.59   Max: 1.32
Current: 1.01

During the past 13 years, the highest EV-to-Revenue of Parnax Lab was 1.32. The lowest was 0.12. And the median was 0.59.

BOM:506128's EV-to-Revenue is ranked better than
78.71% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs BOM:506128: 1.01

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Parnax Lab's stock price is ₹111.40. Parnax Lab's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹157.29. Therefore, Parnax Lab's PS Ratio for today is 0.71.


Parnax Lab EV-to-Revenue Historical Data

The historical data trend for Parnax Lab's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnax Lab EV-to-Revenue Chart

Parnax Lab Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.64 0.84 1.19 0.68

Parnax Lab Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.68 0.37 0.89 0.55

Competitive Comparison of Parnax Lab's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Parnax Lab's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Parnax Lab's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnax Lab's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Parnax Lab's EV-to-Revenue falls into.



Parnax Lab EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Parnax Lab's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1847.420/1832.487
=1.01

Parnax Lab's current Enterprise Value is ₹1,847 Mil.
Parnax Lab's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,832 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnax Lab  (BOM:506128) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Parnax Lab's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=111.40/157.294
=0.71

Parnax Lab's share price for today is ₹111.40.
Parnax Lab's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹157.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Parnax Lab EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Parnax Lab's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Parnax Lab (BOM:506128) Business Description

Traded in Other Exchanges
N/A
Address
104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022
Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.

Parnax Lab (BOM:506128) Headlines

No Headlines